| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/21/2008 | CN101181265A Nitric acid butoconazole cyclodextrin or cyclodextrin derivant clathrate and preparation method as well as application thereof |
| 05/21/2008 | CN101181264A Pharmaceutical composition taking metformin hydrochloride and vigelegting as active component as well as preparing method and uses thereof |
| 05/21/2008 | CN101181263A Treatment of respiratory diseases |
| 05/21/2008 | CN101181262A Application of coumarin monomeric compound in the preparation of medicament for restraining uric acid transportor URAT1 |
| 05/21/2008 | CN101181261A Application of waxberry element in the preparation of medicament for restraining uric acid transportor URAT1 |
| 05/21/2008 | CN101181260A Rabdosia nail element clathrate and pharmaceutical preparation containing the same |
| 05/21/2008 | CN101181259A Sustained-release agent of nitric acid dinitrate and preparation method thereof |
| 05/21/2008 | CN101181258A Lysinepuzinc oral liquid and preparation method thereof |
| 05/21/2008 | CN101181257A Naproxen injection and preparation method thereof |
| 05/21/2008 | CN101181256A Drug complexes for preventing and curing schemic cerebrovaseular disease as well as preparation method thereof |
| 05/21/2008 | CN101181255A Medication new purpose of protocatechualdehyde |
| 05/21/2008 | CN101181254A Slimming appetising capsule containing natural capsicine for promoting blood circulation and reducing blood fat |
| 05/21/2008 | CN101181253A Chloromycetin eyedrops with long shelf-life and preparation method thereof |
| 05/21/2008 | CN101181252A Chloromycetin eyedrops with long shelf-life and preparation method thereof |
| 05/21/2008 | CN101181251A Unimycetin eyedrops and preparation method thereof |
| 05/21/2008 | CN101181250A Antimicrobial compounds |
| 05/21/2008 | CN101181249A Application of turmeric element in the preparation of medicament for restraining uric acid transportor URAT1 |
| 05/21/2008 | CN101181248A Application of white fleece-flower root total acetophenone or acetophenone compounds in the preparation of medicament for curing hepar disease |
| 05/21/2008 | CN101181247A Biphenyl benzyl azoles aerosol and preparation method thereof |
| 05/21/2008 | CN101181246A Compound hydrochloric acid non-sofinadine sustained-release capsules |
| 05/21/2008 | CN101181245A Compound diclofenac natrium capsule |
| 05/21/2008 | CN101181244A Cetirizine pseudoephedrine sustained-release capsules |
| 05/21/2008 | CN101181243A Adenosine cyclophosphate freeze-dry preparations and preparation method thereof |
| 05/21/2008 | CN101181241A Fentanyl composition for nasal administration |
| 05/21/2008 | CN101181239A Unimycetin liquor for eye and preparation method thereof |
| 05/21/2008 | CN101181238A Unimycetin liquor for eye and preparation method thereof |
| 05/21/2008 | CN101181237A Chloromycetin eyedrops with long shelf-lifeand preparation method thereof |
| 05/21/2008 | CN101181235A Tantudinun sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181234A Literdinun sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181233A Gefitinib sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181232A Marseilledinun sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181231A Sustained-release implantation agent of urotrotiken |
| 05/21/2008 | CN101181230A Estramustine sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181229A Busulfan sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181228A Homatropine hydrobromide in-situ gel rubber preparations for dripping eyes and preparation method thereof |
| 05/21/2008 | CN101181225A System for transferring nanometer polyalcohol micelle medicament and preparing method as well as application thereof |
| 05/21/2008 | CN101181224A Solid dispersion of entecavir, pharmaceutical composition and preparation method as well as uses thereof |
| 05/21/2008 | CN101181031A Prescription of eight-flavour health preserving gruel and preparing method |
| 05/21/2008 | CN100389196C Cancer cell vaccine |
| 05/21/2008 | CN100389145C Water gel containing natural high molecule and its radiation preparing method |
| 05/21/2008 | CN100389120C Sealing TGF-betal antisensedingonucleotides and its use in preparing medicine for treating fibrillation related disease |
| 05/21/2008 | CN100389119C (trans)-2-deoxy-2-(fluoromethano)-4-R acyl-cytidine compound, preparation process and use thereof |
| 05/21/2008 | CN100389115C Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 05/21/2008 | CN100389113C Nitrogenous heterocyclic compound and medicine containing the same |
| 05/21/2008 | CN100389109C Non-nucleoside reverse transcriptase inhibitors |
| 05/21/2008 | CN100389105C Substituted benzal cyclopentanone derivatives and their use |
| 05/21/2008 | CN100388953C Composite mucosa immunoadjuvant for oral vaccine |
| 05/21/2008 | CN100388951C Dietetic food composition and dietetic method using such composition |
| 05/21/2008 | CN100388944C Traditional Chinese powder medicine for treating toothache |
| 05/21/2008 | CN100388927C Medicine for treating apoplexy and its preparing process |
| 05/21/2008 | CN100388926C Method for quality control of oral prepn. contg. isatis root |
| 05/21/2008 | CN100388923C Chinese-medicinal preparation and making method for treating acute corneitis and releasing visual fatigue |
| 05/21/2008 | CN100388921C Medicine for promoting healing of wound |
| 05/21/2008 | CN100388920C Oral administration dual polysaccharide Chinese medicine and its preparation method |
| 05/21/2008 | CN100388919C Use of rimexolone in the treatment of dry eye |
| 05/21/2008 | CN100388918C Pharmaceutical compositions based on azetidine derivatives |
| 05/21/2008 | CN100388916C Rate controlling membranes for controlled drug delivery device |
| 05/21/2008 | CN100388915C Eye drop containing tranilast and its preparing process |
| 05/20/2008 | USRE40332 Fungicidal trifluoromethylalkylamino-triazolopyrimidines |
| 05/20/2008 | US7375252 Compounds and method for the inhibition of the expression of VCAM-1 |
| 05/20/2008 | US7375235 Viricides; such as 2-bromo-5,6-dichlorobenzimidazole; cyclizing 4,5-dichloro-o-phenylenediamine with carbonyl di-imidazole |
| 05/20/2008 | US7375230 Using transgenic streptomyces to ferment polyketide for use in the treatment of cancer |
| 05/20/2008 | US7375229 Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods |
| 05/20/2008 | US7375228 Antiinflammatory agents; inflammatory bowel disorders; capable of complexing with a deacetylase catalytic site and/or a metal ion |
| 05/20/2008 | US7375227 May be combined with ACE inhibitors, angiotensin or endothelin receptor antagonists, vasopressin antagonists, alpha- and beta-adrenergic antagonists, TNFalpha antagonists, and peroxisome proliferator activator receptor modulators; cardiovascular, renal, metabolic, pulmonary and psychological disorders |
| 05/20/2008 | US7375226 (6-Chloro-3,4-dihydro-1H-benzo[4,5]thieno[2,3-c]pyridin-2-yl)-(2-isopropoxy-5-methanesulfonyl-phenyl)-methanone; glyicne transporter 1 (GlyT-1) and N-methyl-D-aspartate (NMDA) receptors inhibitor; psychoses, schizophrenia, attention deficit disorders, Alzheimer's disease; cognition activator |
| 05/20/2008 | US7375222 anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient; to improve learning disorder |
| 05/20/2008 | US7375220 Method of treating diseases and conditions associated with an altered level of amyloid β peptides and new enolcarboxamide compounds |
| 05/20/2008 | US7375219 neuronal nitric oxide synthase (nNOS) isoform inhibitors; 2-ethyl-1-(1H-indol-5-yl)-isothiourea; neurogenerative disorders, stroke, reperfusion injury, head trauma, migraine headache, neuropathic pain, drug abuse, hyperalgesia |
| 05/20/2008 | US7375215 Compounds for PDT |
| 05/20/2008 | US7375214 Hydrophobic starch having near-neutral dry product pH |
| 05/20/2008 | US7375212 to modulate the growth of cancer cells, including p53-deficient cancer cells; oligonucleotides, targeted to nucleic acid encoding Aurora B |
| 05/20/2008 | US7375205 Elongase genes and uses thereof |
| 05/20/2008 | US7375204 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity; DNA |
| 05/20/2008 | US7375180 Selecting a compound identified as a TLR8 agonist; andadministering to the cell the compound in an amount that affects at least one TLR8-mediated cellular signaling pathway for eliciting a TLR8-mediated cellular response in a cell |
| 05/20/2008 | US7375138 Cardiovascular disorders; angina pectoris; antiarrhythmia agents |
| 05/20/2008 | US7375137 Methods of treating cancer with HDAC inhibitors |
| 05/20/2008 | US7375136 Such as 1-(4-methanesulphonamidepheoxy)3-(N-methyl-3,4-dichlorophenylethylamino)-2-propanol; synthesis; effective against brain and/or spinal cord tissue acidification disorders |
| 05/20/2008 | US7375135 Fatty acid derivatives; preparation and uses thereof |
| 05/20/2008 | US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 05/20/2008 | US7375133 Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| 05/20/2008 | US7375132 Compounds and methods for inhibiting cellular responses to hypoxia |
| 05/20/2008 | US7375131 NF-κB inhibitors |
| 05/20/2008 | US7375130 ethyl 3-[2-(4-chlorophenyl)-2-oxoethoxy]benzo[b]thiophene-2-carboxylate; non-insulin dependent diabetes, obesity, hypotensive agent; athrosclerosis, retinopathy |
| 05/20/2008 | US7375129 Bis-indole pyrroles useful as antimicrobials agents |
| 05/20/2008 | US7375128 Inhibitors of α1 β2 integrin mediated cell adhesion |
| 05/20/2008 | US7375127 Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) |
| 05/20/2008 | US7375126 Such as N-(5-tert-butyl-23-dihydro-1H-inden-1-yl)-N' -5-isoquinolinylurea therapy for pain, antiinflammatory agents, incintinence, bladder overactivity |
| 05/20/2008 | US7375125 Dietetics, cognition activators, cardiovascular disorders, analgesics, immunomoderators |
| 05/20/2008 | US7375124 2-[3-[2-(4-chlorophenyl)ethoxy]phenylthio]-2-methyl-propanoic acid; antidaibetic agent; insulin resistance, hyperlipemia; increasing HDL-cholesterol levels; low toxicity; microvascular (diabetic retinopathy, neuropathy, nephropathy) and macrovascular (atherosclerosis, obesity, stroke) complications |
| 05/20/2008 | US7375123 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/20/2008 | US7375122 new insecticides and acaricides, and particularly for compounds that have new or atypical modes of action |
| 05/20/2008 | US7375121 Chemical compounds |
| 05/20/2008 | US7375120 Peptide deformylase inhibitors |
| 05/20/2008 | US7375119 Novel inhibitor of FXa that can be administered orally; less toxic; enzyme selectivity; high bioavailability; treatment of diseases caused by thrombi or emboli; N-(5-Chloropyridin-2-yl)-5-methoxy-2-({[trans-4-(3-oxomorpholin-4-yl)cyclohexyl]carbonyl}amino)benzamide |
| 05/20/2008 | US7375118 Phenyl-indole compounds for modulating IgE and Inhibiting cellular proliferation |
| 05/20/2008 | US7375117 Polypeptides |
| 05/20/2008 | US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/20/2008 | US7375114 minimal side effects, selectivity, potency, pharmacokinetics, duration of action; CNS disorders like cognitive, behavioral, mood, autonomic functions; 1-isopropyl-2-oxo-1,2-dihydro-quinoline-3-carboxylic acid {(1S,3R,5R)-8-[3-acetylamino-2-hydroxypropyl]-8-azabicyclo[3.2.1]oct-3-yl}amide |
| 05/20/2008 | US7375113 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |